Rakan Nasreddine

Rue Haute 322
Brussels, BRU 1000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Constrictive pericarditis and tuberculosis: A second look.

Constrictive pericarditis and tuberculosis: A second look.

Journal: European journal of internal medicine

Published: May 08, 2025

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study.

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study.

Journal: Open forum infectious diseases

Published: April 18, 2025

Prevalence of Neisseria meningitidis carriage among men who have sex with men at a sexual health clinic in Brussels, Belgium: a cross-sectional study.

Prevalence of Neisseria meningitidis carriage among men who have sex with men at a sexual health clinic in Brussels, Belgium: a cross-sectional study.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: December 11, 2024

A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study.

A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study.

Journal: Acta clinica Belgica

Published: May 30, 2024

A Characterization of Women Living with HIV in Belgium.

A Characterization of Women Living with HIV in Belgium.

Journal: AIDS research and treatment

Published: April 15, 2024

Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.

Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.

Journal: HIV medicine

Published: December 26, 2022

Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.

Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.

Journal: HIV medicine

Published: February 03, 2022

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization.

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization.

Journal: European journal of drug metabolism and pharmacokinetics

Published: September 24, 2020

Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.

Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.

Journal: Journal of medical virology

Published: September 17, 2020

Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps.

Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps.

Journal: British journal of clinical pharmacology

Published: April 23, 2020

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

Journal: AIDS (London, England)

Published: April 15, 2020

Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020.

Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020.

Journal: Emerging infectious diseases

Published: April 10, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026